Search Results 41-50 of 14939 for Tamoxifen
Tamoxifen pharmacogenetics. A current example of Dr. Ames' research involves defining the role of genetic variation in the risk of cancer recurrence in ...
— For nearly a decade, breast cancer researchers studying the hormone therapy tamoxifen have been divided as to whether genetic differences in a[...].
drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found. The study is published in journal. Cancer Discovery. “Our findings are important, because ...
Vaginal atrophy is common as women age, but it can be worsened in women who've had breast cancer and are receiving endocrine treatments like tamoxifen or ...
Identifying genetic variations in the enzyme CYP2D6, which helps explain why some people with breast cancer don't respond to tamoxifen; Developing a new drug to ...
... tamoxifen, for the treatment of estrogen receptor alpha positive (ERα+) ... Using lab models, we demonstrated that endoxifen is primarily responsible for the ...
It is also used for women who have already had other cancer treatments (eg, tamoxifen). Female hormones that occur naturally in the body can increase the ...
The purpose of this study is to compare the effectiveness of fulvestrant to anastrozole or tamoxifen in treating invasive lobular breast cancer, by measuring ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.